Tag Archives: avandia

Avandia Heavily Restricted by FDA

Diabetes DrugIn July, it looked like the Food and Drug Administration was going to be Avandia’s saving grace, when a 33-person panel voted to allow the diabetes medication to stay on the market. Many felt the decision would stave off litigation against its manufacturer, GlaxoSmithKline. But today, the agency announced a heavy restriction Avandia, although they will not be pulling the drug off the U.S. market. The European Medicines Agency, FDA’s counterpart in the EU, has decided to ban the drug.

(more…)

Avandia Saved by FDA

FDA votes to keep Avandia on the marketTwenty members of a 33-member panel voted to keep diabetes drug Avandia on the market in some form, announced MSNBC. Only 12 members voted to pull the drug from the market, and one panel member abstained from voting. The Food and Drug Administration’s move should hold back litigation against GlaxoSmithKline Plc, Avandia’s maker.

The drug may be associated with increased heart risks, particularly in comparison with Actos, a type two diabetes drug. Research questioning the drug’s safety surfaced in 2024, but much of the data has been deemed inconclusive. (more…)